Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5), a pharmaceutical manufacturer and distributor based in Camarillo, California, was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain (Defense) on October 1, 2020, with a ceiling value of $3,657,817.10 and an ultimate completion date of October 13, 2025. This non-set-aside IDV, stemming from a solicitation posted on September 26, 2019 with a due date of January 30, 2020, establishes Golden State Medical Supply as a prime vendor for the manufacture and distribution of pharmaceutical products classified under North American Industry Classification System (NAICS) code 4610064940. The contract was structured to provide uninterrupted pharmaceutical supply capabilities to federal healthcare systems, with the Medical Supply Chain directing procurement activities on behalf of Defense-affiliated healthcare operations.
Golden State Medical Supply's extensive portfolio of federal pharmaceutical contracts demonstrates the company's competitive capabilities across multiple medication categories, including both branded and generic pharmaceutical products for treatment of various medical conditions. The vendor's established relationships with federal healthcare entities, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service, position it as a critical supplier within the federal pharmaceutical procurement ecosystem. Under this IDV structure, the company is authorized to fulfill delivery orders for pharmaceutical products throughout the contract term, with the ceiling value serving as the maximum obligation threshold. The contract's design reflects standard federal prime vendor program architecture, ensuring consistent pharmaceutical availability across multiple federal healthcare facilities nationwide.